Zdeněk Adam

936 citations
30 papers · 586 indexed · h-index 11
Topics
Multiple Myeloma Research and Treatments (24 papers)Cancer Treatment and Pharmacology (7 papers)Peptidase Inhibition and Analysis (6 papers)
Partner nations
CzechiaAustriaCroatia

In The Last Decade

Zdeněk Adam

27 papers receiving 574 citations

Peers

Zdeněk Adam
Comparison fields: 5 of 49
  • Hematology 521
  • Molecular Biology 418
  • Oncology 313
  • Genetics 81
  • Pathology and Forensic Medicine 43
Replace Mamoun Dib with:
Mamoun Dib France
M. Fox United States
Daniele Derudas Italy
Norbert Pescosta Italy
Raid G. Ossi United States
K. Elias Germany
Luis Palomera Spain
E. Vervessou Greece
Alexandria Petrusich United States
PR Greipp United States
Zdeněk Adam relative to Mamoun Dib France Mamoun Dib's profile →
Citations per field
00.5×8.5×
Mamoun Dib · 1×
Citations per year

Countries citing papers authored by Zdeněk Adam

Since Specialization
Citations

This map shows the geographic impact of Zdeněk Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Adam more than expected).

Fields of papers citing papers by Zdeněk Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zdeněk Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Adam. The network helps show where Zdeněk Adam may publish in the future.

Co-authorship network of co-authors of Zdeněk Adam

This figure shows the co-authorship network connecting the top 25 collaborators of Zdeněk Adam. A scholar is included among the top collaborators of Zdeněk Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeněk Adam. Zdeněk Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 12
4 3
5 4
6 4
7 18
8 1
9 124
10 5
11 5
12 54
13 18
14 0
15 10
16 148
17 4
18 33
19
The therapy of anemia in patients with multiple myeloma
1
20
Therapy of anemia in patients with multiple myeloma.
2

About Zdeněk Adam

Zdeněk Adam is a scholar working on Hematology, Oncology and Occupational Therapy, having authored 30 papers that have together received 586 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Cancer Treatment and Pharmacology (7 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Hematology (521 citations), Oncology (313 citations) and Genetics (81 citations). Zdeněk Adam has collaborated with scholars based in Czechia, Austria and Croatia. Frequent co-authors include Roman Hájek, Marta Krejčí, Luděk Pour, Heinz Ludwig, Viera Sandecká, Richard Greil, Niklas Zojer, Petr Kuglík, Henrieta Grešlíková and Ivan Špıčka. Their work appears in journals such as Blood, PLoS ONE and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026